Firazyr (Shire US Manufacturing Inc.)


Welcome to the PulseAid listing for the Firazyr drug offered from Shire US Manufacturing Inc.. This Bradykinin B2 Receptor Antagonist [EPC],Bradykinin B2 Receptor Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Shire US Manufacturing Inc.
NON-PROPRIETARY NAME: icatibant acetate
SUBSTANCE NAME: ICATIBANT ACETATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Bradykinin B2 Receptor Antagonist [EPC],Bradykinin B2 Receptor Antagonists [MoA]
ROUTE: SUBCUTANEOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2011-08-25
END MARKETING DATE: 0000-00-00


Firazyr HUMAN PRESCRIPTION DRUG Details:

Item DescriptionFirazyr from Shire US Manufacturing Inc.
LABELER NAME: Shire US Manufacturing Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 30(mg/3mL)
START MARKETING DATE: 2011-08-25
END MARKETING DATE: 0000-00-00
PRODUCT ID: 54092-702_1e84d420-d06d-4eaf-954d-91d44232c500
PRODUCT NDC: 54092-702
APPLICATION NUMBER: NDA022150

Other ICATIBANT ACETATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Shire US Manufacturing Inc.Firazyr